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therapist for their knee at one and two years (Table). All of these contrasts
were highly statistically signiﬁcant (p < 0.001).
Conclusions: TKR recipients with severe knee pain in the early
months following surgery have much greater functional deﬁcits and
dissatisfaction with the results of surgery at one, two and ﬁve
year follow-up than patients with less severe pain in the early
months following TKR. These data highlight the health and economic
consequences of severe, persistent pain following TKR. The ﬁndings
underscore the potential value of optmimizing patient selection and
of identifying patients at risk and implementing interventions to reduce
the frequency of severe pain in the early months following TKR.
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Purpose: To analyze the effect of published exercise therapy programs
aimed at reducing pain in patients with osteoarthritis (OA) in the knee,
in order to identify the most optimal exercise program characterized
by number of supervised sessions, type of exercise, relative exercise
intensity and duration of exercise sessions.
Methods: A systematic review and meta-analysis based on published
exercise studies identiﬁed by a comprehensive literature was performed.
Eligible were randomized controlled trials comparing any exercise
intervention with a sham or non-intervention control in patients with
knee OA, using a least one patient reported outcome on pain. Effect sizes
were calculated as standardized mean differences (SMD) estimated from
differences in mean changes between intervention- and control group
after an exercise program, divided by the pooled standard deviation.
SMDs were combined by using a random effects meta-analysis model;
incl. both 95% conﬁdence intervals and prediction intervals. Stratiﬁed
analyses and meta-regression analyses were used to examine study-level
covariates.
Results: Forty one trials with 3274 patients with knee OA comparing 48
interventions with controls were included in the analyses. The pooled
SMD for the reduction of pain was 0.48 [95% CI: 0.36; 0.60] in favor
of exercise, although based on a large between study inconsistency
(I2= 58%). Interpreting this heterogeneity, the 95% prediction interval
(−0.14; 1.10) contains values below 0 and so, although on average the
intervention seems effective, it may not always be beneﬁcial in an
individual setting.
Focusing on pain in pre-speciﬁed stratiﬁed analyses showed almost
similar effects for programs aiming at improving muscle strength, aerobic
capacity or functional performance (SMD[pain]: 0.56, 0.67, and 0.49,
respectively, P = 0.822; pooled SMD= 0.57 [95% CI: 0.44; 0.69], I2= 53%).
Whereas combined programs were less effective in reducing pain (SMD
[pain]: 0.14 [95%CI: −0.11; 0.40], I2=58%), with a statistically signiﬁcant
difference (P < 0.001) between exercise subgroups SMD= 0.43 [95% CI:
0.31; 0.54] in favor of using only one type of exercise.
Heterogeneity in aerobic exercise trials could be explained in a meta-
regression model using numbers of supervised sessions. The reduction
of pain (beta-coefﬁcient = 0.026, [95% CI: 0.01–0.05], I2=23%), was
signiﬁcantly increased with a larger number of supervised exercise
sessions. In resistance exercise heterogeneity could not be explained by
study-level covariates. Stratiﬁed analyses for pain showed larger effect
when focusing on quadriceps strengthening only compared to lower limb
strengthening or strengthening the whole body (SMD[pain]: 0.72, 0.42
respectively, P = 0.04).
Conclusions: Exercise programs have on average a moderate effect for
reducing pain in knee osteoarthritis trials. However, inconsistency across
studies suggests that it will not always imply beneﬁt in comparison
with a matched control group. Stratiﬁed analyses provide evidence that
exercise programs aiming at improving strength, aerobic capacity or
functional performance are more efﬁcacious than combined exercise
programs. While the number of supervised sessions may enhance the
beneﬁts of the aerobic exercise, focusing on the quadriceps only, may
increase beneﬁts of resistance training.
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THE ARCOGEN GENOME-WIDE ASSOCIATION STUDY
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Purpose: To enable a well-powered genome-wide association study
(GWAS) for osteoarthritis (OA), we have formed the arcOGEN Consortium,
a UK-wide collaboration, and have carried out the largest GWAS to date
in 7,410 knee and/or hip OA cases and 11,009 controls.
Methods: OA cases were ascertained based on radiographic evidence of
disease (Kellgren-Lawrence grade ≥2) or clinical evidence of disease to
a level requiring total joint replacement (TJR) and were genotyped on
the Illumina Human610 platform. The study used two different types
of controls: 11,009 population-based, unrelated UK controls which came
from 5 distinct sources (the 1958 Birth Cohort and the UK Blood Donor
Service from the Wellcome Trust Case Control Consortium 2 study, the
1958 Birth Cohort from the T1DGC study, the ALSPAC study and the PoBI
study) genotyped on a variety of Illumina platforms; and 1,828 unrelated,
disease-free controls from the TwinsUK cohort (females only) genotyped
on the Illumina Human610 platform. Analyses were also performed
stratifying the cases by severity, i.e., total joint replacement (TJR) and
by joint and gender. We took forward 129 signals with p < 10−5 and
good quality control properties for in silico replication in 5 other GWAS
(deCODE, EGCUT, GARP, Rotterdam RS1 and RS2 cohorts, and TwinsUK
comprising a total of 5,064 cases and 40,619 controls) and based on these
results we prioritized 26 SNPs with p < 5×10−6 for de novo replication in
2,409 additional arcOGEN cases and 2,319 population-based controls.
Results: Following large-scale replication we have identiﬁed 5 loci
to be associated with OA at the genome-wide signiﬁcance threshold
(p < 5×10−8). The most highly associated SNP, rs6976 in the TJR analysis
(OR for the T allele = 1.12 [1.08–1.16] p =7.2×10−11) is located in
chr3p21.1, a gene-rich region. Three other genome-wide signiﬁcant
signals (rs4836732, rs9350591 and rs10492367) lie in regions/genes
with no apparent role in OA, while rs835487 (association of G allele
with total hip replacement: OR= 1.13 [1.09–1.18] p =1.6×10−8) is located in
intron 2 of the chondroitin 4 sulfotransferase 11, involved in chondrocyte
development during cartilage morphogenesis. We also report association
of rs8044769 at the FTO locus with OA in females, p = 6.85×10−8. It
appears that the FTO SNP exerts its effect on OA through obesity since
the signal is attenuated after adjustment for BMI.
Conclusions: We have identiﬁed ﬁve novel OA loci conferring modest
risk for OA. Functional studies will be needed to identify the underlying
causative genes and understand their involvement in the aetiology
of OA.
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Purpose: We aimed to assess OA susceptibility candidate genes deﬁned
according to previous genetic research in a metaanalysis of 8 genome-
wide association scans (GWAS) performed in subjects of European
ancestry.
Methods: OA susceptibility candidate genes were identiﬁed under the
OA, spinal osteophytosis and invertebral disk displacement phenotypes
in HuGE Navigator, which is a continuously updated knowledge base
in human genome epidemiology. Map positions of loci encompassing
